NEXT GENERATION ANSWERS
FOR BATTLING CANCER
GenomOncology is dedicated to developing software-based solutions for precision oncology that measurably impact patient treatment options. We believe that real-time decision support for oncologists at the point-of-care will accelerate personalized medicine and improve patient outcomes.
We are the leaders in precision oncology solutions.
OUR PRODUCTS
MOLECULAR PATHOLOGY
Our solutions for molecular pathologists create flexible workflows that enable comprehensive analysis and reporting.
CLINICAL ONCOLOGY
Our comprehensive set of software tools enable knowledge-driven clinical decision support at the point-of-care.
CANCER INFORMATICS
Our informatics solutions integrate genomics data, clinical data, and more into visualization tools for big data analyses.
OUR PLATFORM
We Power Clinical Oncology
GenomOncology's Precision Oncology Platform (POP) is at the heart of our platform and products. It provides the molecular and clinical ontologies, variant annotations, and curated knowledge required for the best-in-class decision support. Our POP is scalable and can easily be integrated into a client's other external systems via GO's Application Programming Interfaces (APIs).
OUR CLIENTS
40 + Leading Healthcare Institutions
17 NCI / NCCN - Designated Providers
.png)
20 + Nationally - Recognized Molecular Labs
"As Molecular Pathology labs continue to scale, management of these assays can be an overwhelming challenge, especially if a lab is using multiple tools and databases. Our solution is designed to reduce this lab overhead through direct integration with current infrastructure, creating an automated, seamless flow of data."
Brad Wertz, CEO of GenomOncology.